Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
Azure Cell Therapies has raised $189K in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Azure Cell Therapies's investors include Venture Kick, FONGIT Innovation Fund, Innosuisse, MassChallenge Switzerland, Gebert Rüf Stiftung.
Azure Cell Therapies is headquartered in Geneva, Switzerland.
Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases
Azure Cell Therapies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Azure Cell Therapies — Funding & Investors." VCBacked, July 22, 2025, https://www.vcbacked.co/company/azure-cell-therapies. Accessed July 20, 2026.
VCBacked. (2025). Azure Cell Therapies — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/azure-cell-therapies
{{cite web |title=Azure Cell Therapies — Funding & Investors |url=https://www.vcbacked.co/company/azure-cell-therapies |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated